Zobrazeno 1 - 10
of 85
pro vyhledávání: '"Gregorio T. Obrador"'
Autor:
Gabriela Chico-Barba, Reyna Sámano, Hugo Martínez-Rojano, Rosa María Morales-Hernández, Edgar Barrientos-Galeana, Andrea Luna-Hidalgo, Martha Kaufer-Horwitz, Gregorio T. Obrador, Antonio Rafael Villa-Romero
Publikováno v:
Nutrients, Vol 16, Iss 13, p 2147 (2024)
Pre-pregnancy body mass index (pBMI) is a predictor of gestational weight gain (GWG). However, other factors, such as adipokines and inflammation markers, may also be associated with GWG. The aim of the study was to determine the association of lepti
Externí odkaz:
https://doaj.org/article/08c038bcd73b44bbb58701ebb1af0eb5
Publikováno v:
Kidney International Reports, Vol 5, Iss 7, Pp 973-976 (2020)
Externí odkaz:
https://doaj.org/article/e569127b559844d483417de0dbba4ae7
Autor:
Juan C. Ramírez-Sandoval, Odette Díaz, Ernesto López-Almaraz, Magdalena Madero, Antonio Méndez-Durán, Gregorio T. Obrador-Vera, Rafael Valdez-Ortiz, Ricardo Correa-Rotter
Publikováno v:
Nefrología Latinoamericana, Vol 18, Iss 2 (2021)
El hiperparatiroidismo secundario grave relacionado con la enfermedad renal crónica avanzada es una complicación acompañada de morbimortalidad cuyo diagnóstico y tratamiento son complejos. La interpretación de las mediciones de la hormona parati
Externí odkaz:
https://doaj.org/article/dfac441d98fe47c994b7c321149573bf
Autor:
Elaine Ku, Lucia Del Vecchio, Kai-Uwe Eckardt, Volker H. Haase, Kirsten L. Johansen, Masaomi Nangaku, Navdeep Tangri, Sushrut S. Waikar, Andrzej Więcek, Michael Cheung, Michel Jadoul, Wolfgang C. Winkelmayer, David C. Wheeler, Baris Afsar, Tadao Akizawa, Stefan D. Anker, Mustafa Arici, Jodie L. Babitt, Jonathan Barratt, Jeffrey S. Berns, Anatole Besarab, Sunil Bhandari, Christopher Brown, Aleix Cases, Glenn M. Chertow, Cynthia Delgado, Tillman B. Drüeke, Steven Fishbane, Rafael Gómez, Morgan E. Grams, Takayuki Hamano, Chuan-Ming Hao, Raymond K. Hsu, Kunitoshi Iseki, Isabelle Jordans, Edgar V. Lerma, Francesco Locatelli, Iain C. Macdougall, Jolanta Małyszko, Patrick Maxwell, Lawrence P. McMahon, Gregorio T. Obrador, Marlies Ostermann, Roberto Pecoits-Filho, Farzana Perwad, Simon D. Roger, Ajay K. Singh, Laura Solá, Bruce S. Spinowitz Mai Sugahara, Toshiyuki Takahashi, Mototsugu Tanaka, Tetsuhiro Tanaka, Der-Cherng Tarng, Marcello Tonelli, Yusuke Tsukamoto, Carl P. Walther, Angela Yee-Moon Wang, Bradley A. Warady, Angela C. Webster, Matthew R. Weir, Jay B. Wish, Muh Geot Wong
Publikováno v:
Kidney International.
Autor:
Iain C. Macdougall, Amy Mewborn Meadowcroft, Allison Blackorby, BORUT Cizman, Alexander R Cobitz, Sergio Godoy, Vivekanand Jha, Kirsten L. Johansen, Gearoid McMahon, Gregorio T. Obrador, Muh Geot Wong, Ajay K. Singh
Publikováno v:
American Journal of Nephrology.
Introduction: Hyporesponsiveness to erythropoiesis-stimulating agents (ESAs) affects 10–15% of the chronic dialysis population. We explored baseline characteristics and predictors of ESA hyporesponsiveness in a global randomized cardiovascular outc
Autor:
Vlado Perkovic, Allison Blackorby, Borut Cizman, Kevin Carroll, Alexander R Cobitz, Rich Davies, Tara L DiMino, Vivekanand Jha, Kirsten L Johansen, Renato D Lopes, Lata Kler, Iain C Macdougall, John J V McMurray, Amy M Meadowcroft, Gregorio T Obrador, Scott Solomon, Lin Taft, Christoph Wanner, Sushrut S Waikar, David C Wheeler, Andrzej Wiecek, Ajay K Singh
Publikováno v:
Nephrology Dialysis Transplantation. 37:2157-2170
Background Anaemia is common in chronic kidney disease (CKD) and assessment of the risks and benefits of new therapies is important. Methods The Anaemia Study in CKD: Erythropoiesis via a Novel prolyl hydroxylase inhibitor Daprodustat-Non-Dialysis (A
Autor:
Mejía-Arias Miguel, H. Santiago Lastiri-Quirós, Gregorio T. Obrador, Lina Sofía Palacio-Mejía, Juan Eugenio Hernández-Avila, Mario Márquez Amezcua, Marcela Tamayo-Ortiz, Mariana Alvarez-Aceves, Leslie Guzmán-Sandoval, Mauricio Hernández-Avila, Juan Alfredo Tamayo-Orozco
Background Early detection of chronic kidney disease (CKD) allows health professionals and patients to take actions to slow physical impairment and prevent or delay dialysis or transplantation and their catastrophic costs. In this study, we aimed to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::08de194539ec03e2808b707612ec864d
https://doi.org/10.21203/rs.3.rs-2136675/v1
https://doi.org/10.21203/rs.3.rs-2136675/v1
Autor:
Christoph Wanner, Gregorio T. Obrador, Sushrut S. Waikar, Kevin Carroll, Iain C. Macdougall, Rich Davies, Borut Cizman, Scott D. Solomon, David C. Wheeler, Alexander R. Cobitz, Andrzej Wiecek, Vivekanand Jha, Kirsten L. Johansen, Lata Kler, Allison Blackorby, Vlado Perkovic, Ajay K. Singh, Renato D. Lopes, John J.V. McMurray, Amy Meadowcroft
Publikováno v:
Nephrology Dialysis Transplantation. 37:960-972
Background The Anemia Studies in chronic kidney disease (CKD): Erythropoiesis via a Novel prolyl hydroxylase inhibitor Daprodustat-Dialysis (ASCEND-D) trial will test the hypothesis that daprodustat is noninferior to comparator epoetin alfa or darbep
Autor:
Virginia Pascual-Ramos, Irazú Contreras-Yáñez, Ana Belén Ortiz-Haro, Albert Christiaan Molewijk, Gregorio T. Obrador, Evandro Agazzi
Publikováno v:
Journal of clinical rheumatology : practical reports on rheumaticmusculoskeletal diseases. 28(4)
The patient-doctor relationship (PDR) is a complex phenomenon with strong cultural determinants, which impacts health-related outcomes and, accordingly, does have ethical implications. The study objective was to describe the PDR from medical encounte
Autor:
Ajay K. Singh, Borut Cizman, Kevin Carroll, John J. V. McMurray, Vlado Perkovic, Vivekanand Jha, Kirsten L. Johansen, Renato D. Lopes, Iain C. Macdougall, Gregorio T. Obrador, Sushrut S. Waikar, Christoph Wanner, David C. Wheeler, Andrzej Wiecek, Nicole Stankus, Frank Strutz, Allison Blackorby, Alexander R. Cobitz, Amy M. Meadowcroft, Gitanjali Paul, Prerna Ranganathan, Sangeeta Sedani, Scott Solomon
Publikováno v:
JAMA internal medicine. 182(6)
Daprodustat, a hypoxia-inducible factor prolyl hydroxylase inhibitor, is being evaluated as an oral alternative to conventional erythropoiesis-stimulating agent (ESA) therapy. Few studies of anemia treatment in an incident dialysis (ID) population ha